Bianca Cioni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bianca Cioni has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Annamaria Piva
Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan, Italy
47 shared publications - Claudia Chiodoni
Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
47 shared publications - Daniele Lecis
Fondazione IRCCS Istituto Nazionale dei Tumori
47 shared publications - Francesca Menichetti
Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
47 shared publications - Irene Tripodi
Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. 1
47 shared publications - Laura Botti
Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. 1
47 shared publications
Latest Publications
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
Effect of Jmjd6 silencing in PyMT41C-cells. A) Real-Time PCR showing the levels of Jmjd6 in PyMT-41C cells transfected with non-targeting siRNA (siCtr) or specific for Jmjd6. Graph is the average of two independent experiments. Two-tailed unpaired t student test was applied to calculate statistical significance. B) Western blot performed on conditioned medium collected from PyMT-41C transfected as in A). Red Ponceau is shown as loading control. C) IF to detect ANXA1 levels and D) lipid droplet formation in cell transfected as in A).
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
Effect of Jmjd6 silencing in PyMT41C-cells. A) Real-Time PCR showing the levels of Jmjd6 in PyMT-41C cells transfected with non-targeting siRNA (siCtr) or specific for Jmjd6. Graph is the average of two independent experiments. Two-tailed unpaired t student test was applied to calculate statistical significance. B) Western blot performed on conditioned medium collected from PyMT-41C transfected as in A). Red Ponceau is shown as loading control. C) IF to detect ANXA1 levels and D) lipid droplet formation in cell transfected as in A).
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data Table S2 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
Significant enriched pathways in JMJD6-KO MCF7 and MDA-MB231 cells
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data Table S2 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
Significant enriched pathways in JMJD6-KO MCF7 and MDA-MB231 cells
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
JMJD6 regulates lipid metabolism in MCF7 cells. A) Immunohistochemistry staining for ANXA1 (brown) combined with Oil red-O staining (pink) for lipid droplets visualization in wild-type MCF7 cells B) Gene set enrichment plot for 'Hallmark of Adipogenesis' found to be significantly downregulated in JMJD6 KO MCF7 cells compared to scramble control. C) List of 'Reactome Pathways' found to be regulated by the genes included in the gene set enrichment pathway of 'Hallmark of Adipogenesis' and present in the DEGs list of JMJD6 KO versus scramble MCF7 cells.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
JMJD6 regulates lipid metabolism in MCF7 cells. A) Immunohistochemistry staining for ANXA1 (brown) combined with Oil red-O staining (pink) for lipid droplets visualization in wild-type MCF7 cells B) Gene set enrichment plot for 'Hallmark of Adipogenesis' found to be significantly downregulated in JMJD6 KO MCF7 cells compared to scramble control. C) List of 'Reactome Pathways' found to be regulated by the genes included in the gene set enrichment pathway of 'Hallmark of Adipogenesis' and present in the DEGs list of JMJD6 KO versus scramble MCF7 cells.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data Table S1 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
List of BC patients with ER-positive tumors included in the METABRIC dataset
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data Table S1 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
List of BC patients with ER-positive tumors included in the METABRIC dataset
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
Effect of JMJD6 KO in ER positive and negative cell lines. A) Western blot showing the expression of JMJD6 and ERα in wild-type, scramble or JMJD6 KO BT474 cells both in mass cultures (Left panel) and in single clones (right panel). Vinculin is shown as loading control. B) Volcano plot showing the most upregulated (red) and downregulated (green) genes between scramble and wild-type (parental) MCF7 (left) and MDA-MB231 (right) cells.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
Effect of JMJD6 KO in ER positive and negative cell lines. A) Western blot showing the expression of JMJD6 and ERα in wild-type, scramble or JMJD6 KO BT474 cells both in mass cultures (Left panel) and in single clones (right panel). Vinculin is shown as loading control. B) Volcano plot showing the most upregulated (red) and downregulated (green) genes between scramble and wild-type (parental) MCF7 (left) and MDA-MB231 (right) cells.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
Jmjd6-mediated ANXA1 secretion promotes M2 macrophage differentiation in vitro and ex vivo. A) Mean fluorescence intensity (MFI) of M1 and M2 markers in BMDM differentiated into M0, M1 and M2.** p<0,001, *** means p<0,0001, **** p<0,00001 without conditioned medium. B) Real time PCR showing the expression M1 (CD40 and NOS2) and M2 (CD206 and ARG1) markers in BMDMs differentiated into M0, M1 and M2 macrophages without CM. Datapoints show technical replicates.** p<0,001, *** p<0,0001. C) Gating strategies for FACS analysis on ex vivo mouse samples of Figure 6D. CD45+ leukocytes were gated on live cells, excluding dead cells and debris. In CD45+ population, myeloid cells were analyzed by the expression of CD11b, Gr-1, Ly6C and F4/80 markers. Monocyte-like myleloid-derived immunosuppressive cells (M-MDSC) were identified as Ly6Chigh Gr-1int expression. Granulocyte-like myeloid-derived immunosuppressive cells (G-MDSC) were identified as Gr-1high Ly6Cint cells. M2 macrophages were identified as CD206+ cells in the F4/80 gate. G-MDSC were identified as Gr-1high Ly6Cint cells. M2 macrophages were identified as CD206+ cells in the F4/80 gate.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
Jmjd6-mediated ANXA1 secretion promotes M2 macrophage differentiation in vitro and ex vivo. A) Mean fluorescence intensity (MFI) of M1 and M2 markers in BMDM differentiated into M0, M1 and M2.** p<0,001, *** means p<0,0001, **** p<0,00001 without conditioned medium. B) Real time PCR showing the expression M1 (CD40 and NOS2) and M2 (CD206 and ARG1) markers in BMDMs differentiated into M0, M1 and M2 macrophages without CM. Datapoints show technical replicates.** p<0,001, *** p<0,0001. C) Gating strategies for FACS analysis on ex vivo mouse samples of Figure 6D. CD45+ leukocytes were gated on live cells, excluding dead cells and debris. In CD45+ population, myeloid cells were analyzed by the expression of CD11b, Gr-1, Ly6C and F4/80 markers. Monocyte-like myleloid-derived immunosuppressive cells (M-MDSC) were identified as Ly6Chigh Gr-1int expression. Granulocyte-like myeloid-derived immunosuppressive cells (G-MDSC) were identified as Gr-1high Ly6Cint cells. M2 macrophages were identified as CD206+ cells in the F4/80 gate. G-MDSC were identified as Gr-1high Ly6Cint cells. M2 macrophages were identified as CD206+ cells in the F4/80 gate.
- Open Access
- 1 June 2023
- Published by American Association for Cancer Research (AACR)
Figure S3 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
Effect of Jmjd6 silencing in PyMT41C-cells. A) Real-Time PCR showing the levels of Jmjd6 in PyMT-41C cells transfected with non-targeting siRNA (siCtr) or specific for Jmjd6. Graph is the average of two independent experiments. Two-tailed unpaired t student test was applied to calculate statistical significance. B) Western blot performed on conditioned medium collected from PyMT-41C transfected as in A). Red Ponceau is shown as loading control. C) IF to detect ANXA1 levels and D) lipid droplet formation in cell transfected as in A).
- 1 June 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
Effect of Jmjd6 silencing in PyMT41C-cells. A) Real-Time PCR showing the levels of Jmjd6 in PyMT-41C cells transfected with non-targeting siRNA (siCtr) or specific for Jmjd6. Graph is the average of two independent experiments. Two-tailed unpaired t student test was applied to calculate statistical significance. B) Western blot performed on conditioned medium collected from PyMT-41C transfected as in A). Red Ponceau is shown as loading control. C) IF to detect ANXA1 levels and D) lipid droplet formation in cell transfected as in A).
- Open Access
- 1 June 2023
- Published by American Association for Cancer Research (AACR)
Data from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
Breast cancer is the most common type of cancer in women worldwide, with the luminal subtype being the most widespread. Although characterized by better prognosis compared with other subtypes, luminal breast cancer is still considered a threatening disease due to therapy resistance, which occurs via both cell- and non–cell-autonomous mechanisms. Jumonji domain-containing 6, arginine demethylase and lysine hydroxylase (JMJD6) is endowed with a negative prognostic value in luminal breast cancer and, via its epigenetic activity, it is known to regulate many intrinsic cancer cell pathways. So far, the effect of JMJD6 in molding the surrounding microenvironment has not been explored.Here, we describe a novel function of JMJD6 showing that its genetic inhibition in breast cancer cells suppresses lipid droplet formation and ANXA1 expression, via estrogen receptor alpha and PPARα modulation. Reduction of intracellular ANXA1 results in decreased release in the tumor microenvironment (TME), ultimately preventing M2-type macrophage polarization and tumor aggressiveness.Implications:Our findings identify JMJD6 as a determinant of breast cancer aggressiveness and provide the rationale for the development of inhibitory molecules to reduce disease progression also through the remodeling of TME composition.
- 1 June 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
Breast cancer is the most common type of cancer in women worldwide, with the luminal subtype being the most widespread. Although characterized by better prognosis compared with other subtypes, luminal breast cancer is still considered a threatening disease due to therapy resistance, which occurs via both cell- and non–cell-autonomous mechanisms. Jumonji domain-containing 6, arginine demethylase and lysine hydroxylase (JMJD6) is endowed with a negative prognostic value in luminal breast cancer and, via its epigenetic activity, it is known to regulate many intrinsic cancer cell pathways. So far, the effect of JMJD6 in molding the surrounding microenvironment has not been explored.Here, we describe a novel function of JMJD6 showing that its genetic inhibition in breast cancer cells suppresses lipid droplet formation and ANXA1 expression, via estrogen receptor alpha and PPARα modulation. Reduction of intracellular ANXA1 results in decreased release in the tumor microenvironment (TME), ultimately preventing M2-type macrophage polarization and tumor aggressiveness.Implications:Our findings identify JMJD6 as a determinant of breast cancer aggressiveness and provide the rationale for the development of inhibitory molecules to reduce disease progression also through the remodeling of TME composition.
- Open Access
- 1 June 2023
- Published by American Association for Cancer Research (AACR)
Figure S4 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
Jmjd6-mediated ANXA1 secretion promotes M2 macrophage differentiation in vitro and ex vivo. A) Mean fluorescence intensity (MFI) of M1 and M2 markers in BMDM differentiated into M0, M1 and M2.** p<0,001, *** means p<0,0001, **** p<0,00001 without conditioned medium. B) Real time PCR showing the expression M1 (CD40 and NOS2) and M2 (CD206 and ARG1) markers in BMDMs differentiated into M0, M1 and M2 macrophages without CM. Datapoints show technical replicates.** p<0,001, *** p<0,0001. C) Gating strategies for FACS analysis on ex vivo mouse samples of Figure 6D. CD45+ leukocytes were gated on live cells, excluding dead cells and debris. In CD45+ population, myeloid cells were analyzed by the expression of CD11b, Gr-1, Ly6C and F4/80 markers. Monocyte-like myleloid-derived immunosuppressive cells (M-MDSC) were identified as Ly6Chigh Gr-1int expression. Granulocyte-like myeloid-derived immunosuppressive cells (G-MDSC) were identified as Gr-1high Ly6Cint cells. M2 macrophages were identified as CD206+ cells in the F4/80 gate. G-MDSC were identified as Gr-1high Ly6Cint cells. M2 macrophages were identified as CD206+ cells in the F4/80 gate.
- 1 June 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
Jmjd6-mediated ANXA1 secretion promotes M2 macrophage differentiation in vitro and ex vivo. A) Mean fluorescence intensity (MFI) of M1 and M2 markers in BMDM differentiated into M0, M1 and M2.** p<0,001, *** means p<0,0001, **** p<0,00001 without conditioned medium. B) Real time PCR showing the expression M1 (CD40 and NOS2) and M2 (CD206 and ARG1) markers in BMDMs differentiated into M0, M1 and M2 macrophages without CM. Datapoints show technical replicates.** p<0,001, *** p<0,0001. C) Gating strategies for FACS analysis on ex vivo mouse samples of Figure 6D. CD45+ leukocytes were gated on live cells, excluding dead cells and debris. In CD45+ population, myeloid cells were analyzed by the expression of CD11b, Gr-1, Ly6C and F4/80 markers. Monocyte-like myleloid-derived immunosuppressive cells (M-MDSC) were identified as Ly6Chigh Gr-1int expression. Granulocyte-like myeloid-derived immunosuppressive cells (G-MDSC) were identified as Gr-1high Ly6Cint cells. M2 macrophages were identified as CD206+ cells in the F4/80 gate. G-MDSC were identified as Gr-1high Ly6Cint cells. M2 macrophages were identified as CD206+ cells in the F4/80 gate.
- Open Access
- 1 June 2023
- Published by American Association for Cancer Research (AACR)
Figure S3 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
Effect of Jmjd6 silencing in PyMT41C-cells. A) Real-Time PCR showing the levels of Jmjd6 in PyMT-41C cells transfected with non-targeting siRNA (siCtr) or specific for Jmjd6. Graph is the average of two independent experiments. Two-tailed unpaired t student test was applied to calculate statistical significance. B) Western blot performed on conditioned medium collected from PyMT-41C transfected as in A). Red Ponceau is shown as loading control. C) IF to detect ANXA1 levels and D) lipid droplet formation in cell transfected as in A).
- 1 June 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
Effect of Jmjd6 silencing in PyMT41C-cells. A) Real-Time PCR showing the levels of Jmjd6 in PyMT-41C cells transfected with non-targeting siRNA (siCtr) or specific for Jmjd6. Graph is the average of two independent experiments. Two-tailed unpaired t student test was applied to calculate statistical significance. B) Western blot performed on conditioned medium collected from PyMT-41C transfected as in A). Red Ponceau is shown as loading control. C) IF to detect ANXA1 levels and D) lipid droplet formation in cell transfected as in A).